← Back to patent-cliff list
Rotigotine Microspheres for Injection(Luye Jiaao Pharma)
Tier C — Watch / tradeRotigotine Microspheres for Injection(Luye Jiaao Pharma)
-
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：DRDs
Indications (approved)：Parkinson's disease
Regional status
US
-
EU
-
China
Approved
2024-06-18
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Rotigotine Microspheres for Injection(Luye Jiaao Pharma)?
Approved indications include: Parkinson's disease.
When does the Rotigotine Microspheres for Injection(Luye Jiaao Pharma) patent expire?
No public expiry year is available for Rotigotine Microspheres for Injection(Luye Jiaao Pharma) yet; this page updates once verified.
How do I get a quote for Rotigotine Microspheres for Injection(Luye Jiaao Pharma) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27